India’s First National Study Finds Government-Funded Annual Flu Shots for Seniors Are Cost-Effective and Could Prevent Thousands of Deaths

NEW DELHI — A groundbreaking, multi-site analysis led by the All India Institute of Medical Sciences (AIIMS) reports that introducing a government-funded annual seasonal influenza vaccination programme for Indians aged 60 and older would be highly cost-effective. Published this week in the peer-reviewed journal Influenza and Other Respiratory Viruses, the landmark study reveals that such an initiative could substantially reduce illnesses, hospitalisations, and mortality across the country. The findings suggest that the strategy would be particularly impactful if it prioritises older adults living with chronic underlying conditions like diabetes, heart disease, and chronic lung disease.

The Hidden Burden: 85,000 Annual Deaths Among Indian Seniors

While seasonal influenza is frequently dismissed as a minor ailment, the new research exposes a stark public health reality. For India’s rapidly ageing population, the virus carries lethal consequences.

The AIIMS-led research team estimates that seasonal influenza causes approximately:

• 5.3 million illnesses every year among Indians aged 60 and above.

• More than 36,000 hospitalisations annually.

• Nearly 85,000 deaths each year within this senior demographic alone.

To arrive at these figures, researchers utilised data from the Integrated Network for Surveillance of Influenza and Respiratory Viruses (INSPIRE) network. The robust surveillance initiative tracked more than 7,200 adults aged 60 and older from over 5,400 households across four geographically diverse sites in India between 2018 and 2023. By monitoring influenza infections, hospitalisation rates, clinical outcomes, and direct treatment costs over this five-year period, investigators built a comprehensive picture of the virus’s true economic and physical toll.

Weighing the Costs: Universal vs. Targeted Vaccination

A core component of the study involved advanced economic cost-modelling to determine how a publicly funded immunisation campaign would impact the national healthcare budget. The researchers compared two distinct policy pathways:

The health-economic models clearly indicated that while universal coverage saves the highest absolute number of lives, the targeted approach focusing on vulnerable seniors with comorbidities represents a pragmatic, high-impact first step for public health infrastructure.

Expert Perspectives: Why Local Data Changes the Game

Public health experts have widely praised the study for providing localized, empirical data. Historically, India’s immunization policies have relied heavily on international economic models, which often fail to reflect the unique realities of the subcontinent.

“Having high-quality, locally generated surveillance evidence is an absolute game-changer for adult immunisation policy in India,” says Dr. Sanjay Kumar, an independent public health policy specialist not involved in the AIIMS study.

“Global vaccine economic models simply do not align with India’s specific age distribution, local healthcare delivery costs, or regional disease patterns. This paper provides Indian policymakers with solid, home-grown data to make an informed decision.”

Currently, India does not feature a publicly funded seasonal influenza vaccination programme for its senior citizens, standing in contrast to several Western and middle-income nations where routine annual flu shots are standard public policy for ageing populations.

Implications for Public Health and Policy

As India transitions demographically toward an older average population, the burden of non-communicable diseases—such as diabetes and cardiovascular illnesses—is rising concurrently. When influenza strikes individuals managing these chronic conditions, it frequently triggers severe secondary complications, driving up hospital admissions.

If the government adopts the study’s recommendations, the systemic benefits could extend far beyond individual protection:

• Reduced Hospital Gridlock: Lowering flu-driven admissions during peak winter and monsoon respiratory seasons would alleviate intense pressure on emergency rooms.

• Resource Allocation: Decongesting public wards frees up vital beds, ventilators, and medical personnel to handle other acute medical emergencies.

• Financial Protection: A funded programme protects impoverished families from catastrophic out-of-pocket healthcare expenses due to preventable respiratory failure.

Real-World Limitations and Operational Hurdles

Despite the promising projections, the study’s authors and independent reviewers urge cautious optimism, pointing out several real-world limitations.

First, while the INSPIRE network’s data is methodologically robust, its sampling across four specific regional sites may not perfectly capture the vast climate and seasonal variations that dictate influenza spikes across India’s 28 states and 8 union territories.

Furthermore, health-economic models are inherently built on assumptions. Factors such as fluctuating vaccine procurement prices, real-world vaccine efficacy among the frail elderly, and actual public uptake can all alter the final cost-effectiveness equation.

“The model looks excellent on paper, but the operational mountain we must climb is steep,” notes Dr. Kumar. “Rolling this out nationwide requires substantial parallel investments in cold-chain storage capacity, logistics for remote rural delivery, robust systems to track adverse events, and aggressive public communication campaigns to combat vaccine hesitancy among adults.”

Practical Takeaways for Consumers

For individuals aged 60 and older—and the families who care for them—the message from the medical community is clear: seasonal influenza should not be ignored.

While the wheels of public policy turn slowly toward a potential state-funded rollout, seniors living with diabetes, heart disease, or chronic lung conditions remain at elevated risk today. Public health officials recommend that individuals take immediate, proactive steps to protect their respiratory health:

• Consult a Physician: Speak with a primary care doctor regarding the availability of private-sector seasonal influenza vaccines and confirm if it is appropriate for your current health profile.

• Practice Respiratory Hygiene: Maintain routine hand hygiene, use masks in poorly ventilated areas, and avoid crowded indoor spaces during known local respiratory virus spikes.

• Seek Early Care: Do not dismiss a sudden high fever, cough, or body ache as “just a simple cold.” Early medical consultation and antiviral treatments can prevent severe disease progression.

The AIIMS-led study establishes a powerful baseline, providing the essential data needed to potentially reshape adult preventative healthcare across India for generations to come.

Medical Disclaimer

Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.

References

• Study Citation: AIIMS-led INSPIRE Analysis. “Cost-effectiveness of seasonal influenza vaccination programmes among older adults in India.” Influenza and Other Respiratory Viruses, June 2026.